Covered recipient · General Payments record
KRISTIN MINKOWSKI
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2018–2024
$3,923.04
- Reported across 117 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $755.71 | 36 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $441.74 | 21 |
| Amgen Inc. | $97.23 | 4 |
| Tarsus Pharmaceuticals, Inc. | $50.06 | 2 |
| Alcon Laboratories Inc | $40.54 | 2 |
| Harrow Eye, LLC | $33.53 | 2 |
| Sight Sciences, Inc. | $21.27 | 1 |
| Thea Pharma Inc. | $20.00 | 1 |
| Bausch & Lomb Americas Inc. | $19.92 | 1 |
| Ocular Therapeutix, Inc. | $17.56 | 1 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $13.86 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (36)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $11.10 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105042622 | CMS |
| ABBVIE INC. | $33.17 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105042624 | CMS |
| ABBVIE INC. | $24.06 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105042626 | CMS |
| ABBVIE INC. | $24.83 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105042628 | CMS |
| ABBVIE INC. | $15.88 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105042630 | CMS |
| ABBVIE INC. | $6.60 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105042632 | CMS |
| ABBVIE INC. | $25.48 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105042634 | CMS |
| ABBVIE INC. | $25.28 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105042636 | CMS |
| ABBVIE INC. | $24.93 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105042638 | CMS |
| ABBVIE INC. | $9.39 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105042640 | CMS |
| ABBVIE INC. | $6.43 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105042642 | CMS |
| ABBVIE INC. | $21.86 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105042644 | CMS |
| ABBVIE INC. | $24.12 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105042646 | CMS |
| ABBVIE INC. | $24.61 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105042648 | CMS |
| ABBVIE INC. | $32.38 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105042650 | CMS |
| ABBVIE INC. | $2.28 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105042652 | CMS |
| ABBVIE INC. | $26.37 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105042654 | CMS |
| ABBVIE INC. | $24.63 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105042656 | CMS |
| ABBVIE INC. | $24.99 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105042658 | CMS |
| ABBVIE INC. | $28.33 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105042660 | CMS |
| ABBVIE INC. | $25.02 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105042662 | CMS |
| Alcon Vision LLC | $19.53 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110660451 | CMS |
| Alcon Vision LLC | $21.01 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110660453 | CMS |
| Amgen Inc. | $15.52 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111653329 | CMS |
| Amgen Inc. | $23.96 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111653331 | CMS |
| Amgen Inc. | $24.82 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111653333 | CMS |
| Amgen Inc. | $32.93 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111653327 | CMS |
| Bausch & Lomb Americas Inc. | $19.92 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140390108 | CMS |
| Harrow Eye, LLC | $16.97 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145609991 | CMS |
| Harrow Eye, LLC | $16.56 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145609993 | CMS |
| Ocular Therapeutix, Inc. | $17.56 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148200677 | CMS |
| Sight Sciences, Inc. | $21.27 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151928013 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $13.86 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152171024 | CMS |
| Tarsus Pharmaceuticals, Inc. | $23.10 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139117752 | CMS |
| Tarsus Pharmaceuticals, Inc. | $26.96 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139117754 | CMS |
| Thea Pharma Inc. | $20.00 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1074543237 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.